Please provide your email address to receive an email when new articles are posted on . In a video, Jay B. Wish, MD, clinical medicine professor at Indiana University School of Medicine reports the ...
The novel erythropoetic protein darbepoetin alfa exhibits enhanced biological activity and increased serum half-life compared with other erythropoetic agents used to treat chemotherapy-related anemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback